In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Project Team

Developer NICE Clinical Guideline Updates Team

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
18 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
10 March 2020 Declaration of interests
20 January 2020 Committee meeting
02 January 2020 Stakeholder list updated
03 September 2019 Committee list updated
18 December 2018 Scope published
14 September 2018 - 24 October 2018 Committee member recruitment
14 September 2018 - 12 October 2018 Draft scope consultation
01 October 2018 Development of this guideline will pause following scope consultation due to rescheduling of the programme.

For further information on the guideline development process, please read how we develop NICE guidelines